论文部分内容阅读
作为推广“互联网+医疗”的重要环节,网络药品零售试点工作的暂停对医药领域内诸多参与方来说是不小的打击。7月底,国家食品药品监督管理总局(以下简称“食药监总局”)分别通知河北省、上海市、广东省食品药品监督管理局,要求结束互联网第三方平台药品网上零售试点工作,所涉电商平台天猫医药馆、1号店与八百方均需在8月1日起陆续停止互联网药品零售业务。有业内分析人士指出,此次试点结束属于正常程序,今后预计会有更详细的规范政策出台,进而梳理市场。
As an important link in popularizing “Internet + Medical”, the suspension of online pharmaceutical retail pilot work is a big blow to many participants in the pharmaceutical field. By the end of July, the State Food and Drug Administration (hereinafter referred to as the “SFDA”) respectively notified Hebei Province, Shanghai Municipality and Guangdong Food and Drug Administration to end the online retail pilot of third-party platform drugs online The Tmall Pharmacy, the No. 1 store and the eight hundred parties involved in the e-commerce platform, are required to stop the online pharmaceutical retailing business from August 1 onwards. Some industry analysts pointed out that the end of the pilot is a normal procedure, the future is expected to have a more detailed regulatory policies introduced, and then sort out the market.